Growth Hormone Treatment Completed Phase Trials for Pegvisomant (DB00082)

IndicationStatusPhase
DBCOND0043256 (Growth Hormone Treatment)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs